Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Alzheimer'S Research & Therapy|October 23, 2012
Potential sources of interference on Abeta immunoassays in biological samplesHugo Vanderstichele, Erik Stoops, Eugeen Vanmechelen, et al.Neurobiology of Disease|September 24, 2020
How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphologySenthil T Kumar, Somanath Jagannath, Cindy Francois, et al.Clinical Chemistry and Laboratory Medicine|May 6, 2021
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementSilvia Paciotti, Erik Stoops, Cindy François, et al.Journal of Neurochemistry|July 3, 2019
Parkinson's disease biomarkers based on α-synucleinMuneera Fayyad, Safa Salim, Nour Majbour, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 22, 2023
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian SyndromesAndrea Mancini, Erik Stoops, Leentje Demeyer, et al.Alzheimer'S Research & Therapy|June 8, 2017
Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)Hugo Vanderstichele, Leentje Demeyer, Shorena Janelidze, et al.Journal of Alzheimer'S Disease : JAD|June 4, 2016
Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding TubesHugo Marcel Johan Vanderstichele, Shorena Janelidze, Leentje Demeyer, et al.Journal of Parkinson'S Disease|May 9, 2022
Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN ProteoformsLara Petricca, Nour Chiki, Layane Hanna-El-Daher, et al.Stroke|October 26, 2018
C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging MarkersSaima Hilal, M Arfan Ikram, Marcel M Verbeek, et al.Alzheimer'S Research & Therapy|July 2, 2018
Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based studySaima Hilal, Frank J Wolters, Marcel M Verbeek, et al.Pageof 6